Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Esophageal Diseases
>>
PI3 Kinase Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
MK-2206
/ Merck (MSD)
Estybon
(rigosertib) / Traws Pharma, SymBio Pharma, Knight Therap
